CENTOGENE Receives French Research Tax Credit Accreditation
CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, Jan. 24, 2024 (GLOBE NEWSWIRE) — Centogene N.V. (Nasdaq:CNTG), the essential life science partner for data-driven answers in rare and neurodegenerative diseases, today announced that it has been recognized by the French Ministry of Higher Education and Research as a qualified organization to support partners conducting R&D projects in France. Accordingly, it has received accreditation under the French R&D tax credit initiative (‘Crédit d’Impôt Recherche’, CIR) for a three-year period.
Related news for (CNTG)
- CENTOGENE and the Laboratory of Human Genetics of Infectious Diseases at Institut Imagine Announce Rare Disease Research Collaboration
- CENTOGENE and The Michael J. Fox Foundation Announce Research Project to Validate Genetic Risk Factors of Parkinson’s Disease Using Multiomics
- CENTOGENE Announces Preliminary Full Year 2023 Revenue
- CENTOGENE Reports Full Year 2022 Financial Results